http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03055995-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5bfb9284487a1f5671568827c7682a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a69146168148d9aaf7fbd7817d339b49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8adb45f59a7cfe9ad337f51e4c48e2f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb9b44f4eaed31c547930ecc58bf8f7e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-20 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-55 |
| filingDate | 2002-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3b858c496f7f720071399a4bbd9fdab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de287faa13a5f537c3b75f22018bc53e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_884b7504f3465e9399c1c6fefa14d5d0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac9bd79d5662378277f2c3c9b9a664ac |
| publicationDate | 2003-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-03055995-A2 |
| titleOfInvention | Lipase genes and proteins |
| abstract | Lipase proteins play important role in tissue or plasma lipid and lipoprotein metabolism and function to hydrolize lipid such as triglycerides. Disease associates with lipase function indludes lipase deficiency, atherosclerosis, fatty liver disease and dyslipidemias, such as hypercholesterolemia, hypertriglyceridemia, mixed (combined) dyslipidemia, lipid or lipoprotein deficient states, and/or any other tissue or plasma disorders of lipid or lipoprotein metabolism. The invention describes two novel lipase proteins (LPDL and LPDLR) and the nucleic acids encoding them as well as the regulatory sequences controlling their gene expression. The invention relates to use of LPDL and/or LPDLR nucleic acid or their proteins in modulating cellular process in disease state or in normal energy homeostasis. The invention also relate to their modulators, antibodies, antisense oligonucleotides and diagnostic assays, the screening for mutations, gene therapy, use of their promoters to control gene expression, and their industrial use in food industry and oil and waste management. The invention also relates methods of drug screening for LPDL and LPDLR, their therapeutic use in humans and their use as pharmaceutical compositions. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106884008-B http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106884008-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015141137-A |
| priorityDate | 2001-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1247.